Denda K, Kako Y, Kitagawa N, Koyama T: "Assessment of depressive symptoms in Japanese school children and adolescents using the Birleson depression self-rating scale", International Journal of Psychiatry in Medicine36(2), 231-241, (2006)*
Tetsuya Ando, Gen Komaki, Kenzo Denda et al.: "Possible Role of Preproghrelin Gene Polymorphisms in Susceptibility to Bulimia Nervosa", American Journal of Medical Genetics Part B, (Neuropsychiatric Genetics)141B, 929-934, (2006)*
Nomura M, Kusumi I, Kaneko M, Masui T, Daiguji M, Ueno T, Koyama T, Nomura Y: "Involvement of a polymorphism in the 5-HT2A receptor gene in impulsive behavior", Psychopharmacology187, 30-35, (2006)*
Kohno T, Shiga T, Kusumi I, Matsuyama T, Kageyama H, Katoh C, Koyama T, Tamaki N: "Left temporal perfusion associated with suspiciousness score on the brief psychiatric rating scale in schizophrenia", Psychiatry Res. Neuroimaging147, 163-171, (2006)*
Akimoto T, Kusumi I, Suzuki K, Koyama T: "Effects of calmodulin and protein kinase C modulators on transient Ca2+ increase and capacitative Ca2+ entry in human platelets:relevant to pathophysiology of bipolar disorder", Prog. NeuroPsychopharmacol Biol. Psychiatry31: pp.136-141, (2007)*
Inoue T, Nakagawa S, Izumi T, Kitaichi Y, Koyama T: "Effect of combined treatment with noradrenaline and serotonin reuptake inhibitors on conditioned freezing, Eur J Pharmacol540, 91-95, (2006)*
Inoue T, Nakagawa S, Kitaichi Y, Izumi T, Tanaka T, Masui T, Kusumi I, Denda K, Koyama T: "Long-term outcome of antidepressant-refractory depression: The relevance of unrecognized bipolarity.", J Affect Disord95, 61-67, (2006)*
Abekawa T, Ito K, Koyama T: "Prenatal exposure to an NMDA receptor antagonist, MK-801 reduces density of parvalbumin-immunoreactive GABAergic neurons in the medial prefrontal cortex and enhances phencyclidine-induced hyperlocomotion but not behavioral sensitization to methamphetamine in postpubertal rats.:, Psychopharmacology, (in press).
Abekawa T, Ito K, Koyama T: "Role of the simultaneous enhancement of NMDA and dopamine D1 receptor-mediated neurotransmission in the effects of clozapine on phencyclidine-induced acute increases in glutamate levels in the rat medial prefrontal cortex", Naunyn-Schmiederberg's Arch Pharmacology374:177-193, (2006)
Izumi T, Inoue T, Kitaichi Y, Nakagawa S, Koyama T: "Target brain sites of the anxiolytic effect of citalopram, a selective serotonin reuptake inhibitor", Eur J Pharmacol534, 129-32, (2006).
Li X, Inoue T, Abekawa T, Weng S, Nakagawa S, Izumi T, Koyama T: "5-HT1A receptor agonist affects fear conditioning through stimulations of the postsynaptic 5-HT1A receptors in the hippocampus and amygdala", Eur J Pharmacol. 532, 74-80., (2006).
Du J, Suzuki K, Wei Y, Wang Y, Blumenthal R, Chen G, Falke C, Zarate CA Jr., Manji HK: "The anticonvulsants lamotrigine, riluzole and valproate differentially regulate AMPA receptor membrane localization:relationship to clinical effects in mood disorders", Neuropsychopharmacology32(4), 793-802, (2007).
Kitaichi Y, Inoue T, Nakagawa S, Izumi T, Koyama T,: "Effect of co-administration of subchronic lithium pretreatment and acute MAO inhibitors on extracellular monoamine levels and the expression of contextual conditioned fear in rats", Eur J Pharmacol.532(3), 236-45, (2006).*
Koki, Ito; Tomohiro, Abekawa; Tsukasa, Koyama: "Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine". Psychopharmacology, (Berl).2006 Aug, (3); 187, 293-302. Epub 2006 Jun 1
Koki, Ito; Tomohiro, Abekawa; Tsukasa, Koyama: "Valproate blocks high-dose methamphetamine-induced behavioral cross-sensitization to locomotion-inducing effect of dizocilpine, (MK-801), but not methamphetamine", Psychopharmacology, (Berl).2006 Jul, (4); 186, 525-533. Epub 2006 Apr 1
, : "", Bulletin of Depression and Anxiety Disorders4(7), 4-6, (2007)
Murahsita M, Inoue T, Kusumi I, Nakagawa S, Itoh K, Tanaka T, Izumi T, Hosoda H, Kangawa K, Koyama T: "Glucose and lipid metabolism of long-term risperidone mono-therapy in patients with schizophrenia", Psychiatry and Clinical Neuroscience61, 54-58, (2007) *
